3M vs Colgate-Palmolive
This page compares 3M and Colgate-Palmolive, highlighting their business models, financial performance, and market context. It presents neutral, accessible information to help readers understand each company’s approach and position in the market. The content focuses on contrasts and similarities without promotion or forecast. Educational content, not financial advice.
This page compares 3M and Colgate-Palmolive, highlighting their business models, financial performance, and market context. It presents neutral, accessible information to help readers understand each ...
Why It's Moving
3M Grapples with Insider Selling and Slipping Shares Amid Mixed Earnings Signals
- CAO Theresa Reinseth offloaded 5,145 shares worth nearly $889K on Feb. 11, slashing her stake by over 66%, sparking questions about internal confidence.
- Shares dropped 4.8% in the last 7 days through March 11, lagging the industrials sector's gains and trading around $155 amid heightened volatility.
- Q3 results featured $1.83 EPS topping estimates by $0.03, a dividend hike to $0.78 quarterly, and FY2026 guidance of $8.50-$8.70, yet revenue slightly missed at $6B.
CL Faces Analyst Warnings of -8% Downside Despite Dividend Boost and Board Refresh
- Dividend increase to $0.53 per share (annualized $2.12) underscores 131 years of uninterrupted payouts, reinforcing reliability for income-focused investors.
- Election of Bristol Myers Squibb CEO Christopher Boerner to the board effective March 15 brings pharma expertise, while Steven Cahillane steps down after strong service.
- Consensus 'Moderate Buy' rating from brokerages contrasts with downside warnings, highlighting mixed views on valuation in a low-volatility staples environment.
3M Grapples with Insider Selling and Slipping Shares Amid Mixed Earnings Signals
- CAO Theresa Reinseth offloaded 5,145 shares worth nearly $889K on Feb. 11, slashing her stake by over 66%, sparking questions about internal confidence.
- Shares dropped 4.8% in the last 7 days through March 11, lagging the industrials sector's gains and trading around $155 amid heightened volatility.
- Q3 results featured $1.83 EPS topping estimates by $0.03, a dividend hike to $0.78 quarterly, and FY2026 guidance of $8.50-$8.70, yet revenue slightly missed at $6B.
CL Faces Analyst Warnings of -8% Downside Despite Dividend Boost and Board Refresh
- Dividend increase to $0.53 per share (annualized $2.12) underscores 131 years of uninterrupted payouts, reinforcing reliability for income-focused investors.
- Election of Bristol Myers Squibb CEO Christopher Boerner to the board effective March 15 brings pharma expertise, while Steven Cahillane steps down after strong service.
- Consensus 'Moderate Buy' rating from brokerages contrasts with downside warnings, highlighting mixed views on valuation in a low-volatility staples environment.
Investment Analysis
3M
MMM
Pros
- 3M has raised its 2025 earnings outlook, reflecting improved profitability and successful execution of its turnaround strategy.
- The company has delivered strong organic sales growth and expanded operating margins, driven by cost controls and a shift towards higher-margin products.
- Recent settlements of long-standing legal issues have reduced uncertainty and cleared the path for future growth and investment.
Considerations
- Despite recent gains, 3M's valuation scores only moderately on undervaluation metrics, suggesting limited upside potential for new investors.
- The stock has experienced significant volatility, with technical forecasts indicating possible downward pressure in the near term.
- Ongoing restructuring and product mix changes carry execution risks that could affect future performance.
Pros
- Colgate-Palmolive maintains a strong global brand presence and consistent demand for its consumer products across multiple categories.
- The company operates with a stable balance sheet and a history of reliable dividend payments, appealing to income-focused investors.
- Colgate-Palmolive benefits from a diversified product portfolio, including oral care, personal care, and pet nutrition segments.
Considerations
- Revenue growth has been relatively slow, constrained by mature markets and limited pricing power in key regions.
- The company faces increasing competition from private labels and new entrants in the consumer goods sector.
- Exposure to foreign exchange fluctuations and input cost volatility can impact profitability.
Related Market Insights
Reputation Shields: The Brands That Survive Any Storm
Discover 'Reputation Shields' – a Neme of crisis-proof brands with deep consumer trust. Invest in resilient companies offering consistent dividends via Nemo. Start from $1.
Aimee Silverwood | Financial Analyst
July 25, 2025
Patient Builders: The Steady Compounders Outpacing Market Volatility
Discover Patient Builders: companies like Microsoft, J&J, & P&G focused on sustainable long-term growth. Invest in steady compounders via fractional shares on Nemo.
Aimee Silverwood | Financial Analyst
July 25, 2025
Related Market Insights
Reputation Shields: The Brands That Survive Any Storm
Discover 'Reputation Shields' – a Neme of crisis-proof brands with deep consumer trust. Invest in resilient companies offering consistent dividends via Nemo. Start from $1.
Aimee Silverwood | Financial Analyst
July 25, 2025
Patient Builders: The Steady Compounders Outpacing Market Volatility
Discover Patient Builders: companies like Microsoft, J&J, & P&G focused on sustainable long-term growth. Invest in steady compounders via fractional shares on Nemo.
Aimee Silverwood | Financial Analyst
July 25, 2025
3M (MMM) Next Earnings Date
3M (MMM) is estimated to report its next earnings for the Q1 2026 quarter between April 21 and April 28, 2026, with several sources converging on April 21 or April 28 based on historical patterns following the January 20, 2026 release. This date remains unconfirmed by the company. Investors should monitor official announcements for the precise timing and conference call details.
Colgate-Palmolive (CL) Next Earnings Date
Colgate-Palmolive (CL) is expected to report its next earnings for the first quarter of 2026 in late April or early May, aligning with its historical quarterly pattern following the Q4 2025 release. The specific date has not been confirmed, but investors should monitor for the official announcement typically issued a few weeks prior. This report will cover the quarter ending March 31, 2026.
3M (MMM) Next Earnings Date
3M (MMM) is estimated to report its next earnings for the Q1 2026 quarter between April 21 and April 28, 2026, with several sources converging on April 21 or April 28 based on historical patterns following the January 20, 2026 release. This date remains unconfirmed by the company. Investors should monitor official announcements for the precise timing and conference call details.
Colgate-Palmolive (CL) Next Earnings Date
Colgate-Palmolive (CL) is expected to report its next earnings for the first quarter of 2026 in late April or early May, aligning with its historical quarterly pattern following the Q4 2025 release. The specific date has not been confirmed, but investors should monitor for the official announcement typically issued a few weeks prior. This report will cover the quarter ending March 31, 2026.
Which Baskets Do They Appear In?
Reputation Shields
Invest in companies with brands so powerful they're practically bulletproof. These carefully selected stocks represent iconic names with decades of consumer trust, giving them unique protection against scandals and market turbulence that would devastate lesser companies.
Published: June 17, 2025
Explore BasketPatient Builders
Companies that create lasting value through quality and customer trust rather than chasing quick profits. This carefully curated collection showcases market leaders who've proven that patient, sustainable growth leads to superior long-term returns.
Published: June 17, 2025
Explore BasketWhich Baskets Do They Appear In?
Reputation Shields
Invest in companies with brands so powerful they're practically bulletproof. These carefully selected stocks represent iconic names with decades of consumer trust, giving them unique protection against scandals and market turbulence that would devastate lesser companies.
Published: June 17, 2025
Explore BasketPatient Builders
Companies that create lasting value through quality and customer trust rather than chasing quick profits. This carefully curated collection showcases market leaders who've proven that patient, sustainable growth leads to superior long-term returns.
Published: June 17, 2025
Explore BasketBuy MMM or CL in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Comparisons
3M vs Ambev
A neutral, educational comparison of 3M and Ambev, covering business models, financial performance, diversification, and market context to help researchers decide where to start.
3M vs Kimberly-Clark
This page compares 3M and Kimberly-Clark, analysing business models, financial performance and market context to help readers decide which shares to research further.
3M vs Diageo
A neutral 3M vs Diageo comparison of business models, financial performance, and market context to help readers decide which company to research further.